MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $549,509 | +20.5% | 12,615 | -0.1% | 0.01% | +22.2% |
| Q2 2023 | $456,069 | -2.8% | 12,623 | +0.1% | 0.01% | -18.2% |
| Q1 2023 | $469,026 | -17.9% | 12,615 | 0.0% | 0.01% | -31.2% |
| Q4 2022 | $571,586 | -35.1% | 12,615 | -0.0% | 0.02% | -33.3% |
| Q3 2022 | $881,000 | +4.0% | 12,621 | +0.0% | 0.02% | -7.7% |
| Q2 2022 | $847,000 | -18.4% | 12,615 | -0.1% | 0.03% | +4.0% |
| Q1 2022 | $1,038,000 | -43.9% | 12,624 | +0.1% | 0.02% | -41.9% |
| Q4 2021 | $1,850,000 | -18.6% | 12,615 | -1.8% | 0.04% | -28.3% |
| Q3 2021 | $2,273,000 | – | 12,849 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |